Invention Grant
- Patent Title: Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
-
Application No.: US18518110Application Date: 2023-11-22
-
Publication No.: US12023328B2Publication Date: 2024-07-02
- Inventor: Michael D. Kaufman , Scott Bone , Corey Bloom , Fred Jordan
- Applicant: Deciphera Pharmaceuticals, LLC
- Applicant Address: US MA Waltham
- Assignee: Deciphera Pharmaceuticals, LLC
- Current Assignee: Deciphera Pharmaceuticals, LLC
- Current Assignee Address: US MA Waltham
- Agency: Goodwin Procter LLP
- Main IPC: A61K31/4375
- IPC: A61K31/4375 ; A61K9/00 ; A61K9/10 ; A61K47/38
Abstract:
Provided herein are low impurity compositions comprising a compound represented by Formula (I):
which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof.
which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof.
Public/Granted literature
Information query
IPC分类:
